USD 0.89
(-8.75%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | -768 Thousand USD | -116.07% |
2023 | -355.44 Thousand USD | -80.5% |
2022 | -196.92 Thousand USD | -8.29% |
2021 | -181.84 Thousand USD | -413.23% |
2020 | -35.43 Thousand USD | -144.89% |
2019 | -14.46 Thousand USD | -677.43% |
2018 | -1861.00 USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | -141 Thousand USD | 27.11% |
2024 FY | -768 Thousand USD | -116.07% |
2024 Q4 | 672 Thousand USD | 616.92% |
2024 Q2 | -180 Thousand USD | -27.66% |
2024 Q3 | -130 Thousand USD | 27.78% |
2023 FY | -355.44 Thousand USD | -80.5% |
2023 Q1 | -50.35 Thousand USD | 13.55% |
2023 Q4 | -193.44 Thousand USD | -242.12% |
2023 Q3 | -56.54 Thousand USD | -2.63% |
2023 Q2 | -55.09 Thousand USD | -9.41% |
2022 FY | -196.92 Thousand USD | -8.29% |
2022 Q1 | -43.27 Thousand USD | 7.6% |
2022 Q2 | -48.41 Thousand USD | -11.87% |
2022 Q3 | -46.98 Thousand USD | 2.94% |
2022 Q4 | -58.24 Thousand USD | -23.97% |
2021 Q2 | - USD | 0.0% |
2021 Q4 | -46.83 Thousand USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 FY | -181.84 Thousand USD | -413.23% |
2020 FY | -35.43 Thousand USD | -144.89% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2019 FY | -14.46 Thousand USD | -677.43% |
2019 Q1 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2018 FY | -1861.00 USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 2.55 Million USD | 130.118% |
BrainsWay Ltd. | 23.09 Million USD | 103.326% |
Cerus Corporation | 86.4 Million USD | 100.889% |
Envoy Medical, Inc. | -473 Thousand USD | -62.368% |
electroCore, Inc. | 13.22 Million USD | 105.807% |
Helius Medical Technologies, Inc. | 61 Thousand USD | 1359.016% |
IceCure Medical Ltd | 1.3 Million USD | 159.077% |
Inogen, Inc. | 126.69 Million USD | 100.606% |
OrthoPediatrics Corp. | 111.25 Million USD | 100.69% |
Lucid Diagnostics Inc. | -6.05 Million USD | 87.306% |
Monogram Orthopaedics, Inc. | -47.33 Thousand USD | -1522.444% |
MaxCyte, Inc. | 36.54 Million USD | 102.101% |
NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | 268.23% |
Nexalin Technology, Inc. | 85.06 Thousand USD | 1002.892% |
Orthofix Medical Inc. | 486.27 Million USD | 100.158% |
PAVmed Inc | -3.96 Million USD | 80.645% |
Rapid Micro Biosystems, Inc. | -5.48 Million USD | 85.998% |
RxSight, Inc. | 53.76 Million USD | 101.428% |
Sight Sciences, Inc. | 69.17 Million USD | 101.11% |
SI-BONE, Inc. | 109.42 Million USD | 100.702% |
TELA Bio, Inc. | 40.11 Million USD | 101.915% |
Treace Medical Concepts, Inc. | 151.93 Million USD | 100.505% |
Vivos Therapeutics, Inc. | 8.27 Million USD | 109.285% |
Acutus Medical, Inc. | -3.13 Million USD | 75.518% |
Talis Biomedical Corporation | 371 Thousand USD | 307.008% |
Spectral AI, Inc. | 7.88 Million USD | 109.746% |
Nano-X Imaging Ltd. | -6.59 Million USD | 88.35% |
CVRx, Inc. | 33.03 Million USD | 102.325% |
DIH Holding US, Inc. Warrants | - USD | Infinity% |
PetVivo Holdings, Inc. | 739.52 Thousand USD | 203.85% |
Bioventus Inc. | 328.19 Million USD | 100.234% |
Venus Concept Inc. | 52.16 Million USD | 101.472% |
TriSalus Life Sciences, Inc. | 15.9 Million USD | 104.828% |
LivaNova PLC | 771.25 Million USD | 100.1% |
908 Devices Inc. | 25.32 Million USD | 103.033% |
Alphatec Holdings, Inc. | 310.2 Million USD | 100.248% |
Nemaura Medical Inc. | -1.47 Million USD | 47.981% |
NeuroPace, Inc. | 48.12 Million USD | 101.596% |
LENSAR, Inc. | 21.1 Million USD | 103.639% |
Apyx Medical Corporation | 14.12 Million USD | 105.438% |
Cutera, Inc. | 41.49 Million USD | 101.851% |
STRATA Skin Sciences, Inc. | 18.46 Million USD | 104.16% |
BioSig Technologies, Inc. | 18 Thousand USD | 4366.667% |
Anika Therapeutics, Inc. | 103.08 Million USD | 100.745% |
ClearPoint Neuro, Inc. | 13.61 Million USD | 105.641% |
Integra LifeSciences Holdings Corporation | 888.39 Million USD | 100.086% |
Axonics, Inc. | 274.55 Million USD | 100.28% |
Outset Medical, Inc. | 29 Million USD | 102.648% |
IRIDEX Corporation | 21.8 Million USD | 103.522% |
PROCEPT BioRobotics Corporation | 71.04 Million USD | 101.081% |
IRadimed Corporation | 50.15 Million USD | 101.531% |
Tivic Health Systems, Inc. | 287 Thousand USD | 367.596% |
INVO Bioscience, Inc. | 1.08 Million USD | 170.709% |
Telesis Bio, Inc. | 16.95 Million USD | 104.531% |
Viemed Healthcare, Inc. | 112.78 Million USD | 100.681% |
Varex Imaging Corporation | 256.9 Million USD | 100.299% |
Quipt Home Medical Corp. | 163.84 Million USD | 100.469% |
Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | -89.163% |
Pulmonx Corporation | 50.75 Million USD | 101.513% |
Dynatronics Corporation | 7.63 Million USD | 110.059% |
ReShape Lifesciences Inc. | 5.54 Million USD | 113.843% |
Semler Scientific, Inc. | 61.2 Million USD | 101.255% |
InMode Ltd. | 411.34 Million USD | 100.187% |
Bruker Corporation | 1.51 Billion USD | 100.051% |
Cytosorbents Corporation | 22.39 Million USD | 103.43% |
DexCom, Inc. | 2.28 Billion USD | 100.034% |
Align Technology, Inc. | 2.71 Billion USD | 100.028% |
Viveve Medical, Inc. | 620 Thousand USD | 223.871% |
ZimVie Inc. | 290.38 Million USD | 100.264% |
Movano Inc. | -158 Thousand USD | -386.076% |
Cytek Biosciences, Inc. | 109.42 Million USD | 100.702% |
Nexalin Technology, Inc. | 85.06 Thousand USD | 1002.892% |
DIH Holdings US, Inc. Class A Common Stock | - USD | Infinity% |
Tandem Diabetes Care, Inc. | 367.69 Million USD | 100.209% |
Profound Medical Corp. | 4.51 Million USD | 117.014% |
Insulet Corporation | 1.15 Billion USD | 100.066% |
enVVeno Medical Corporation | -546 Thousand USD | -40.659% |
Surmodics, Inc. | 93.05 Million USD | 100.825% |
iCAD, Inc. | 14.53 Million USD | 105.283% |
Nuwellis, Inc. | 4.98 Million USD | 115.412% |
Biotricity, Inc. | 8.35 Million USD | 109.191% |
iRhythm Technologies, Inc. | 331.8 Million USD | 100.231% |
Aethlon Medical, Inc. | -359.05 Thousand USD | -113.894% |
InspireMD, Inc. | 1.8 Million USD | 142.501% |
PAVmed Inc. | -3.96 Million USD | 80.645% |
BIOLASE, Inc. | 16.72 Million USD | 104.592% |
Beyond Air, Inc. | -1.3 Million USD | 41.239% |
FONAR Corporation | 45.14 Million USD | 101.701% |
AxoGen, Inc. | 127.87 Million USD | 100.601% |
Vivani Medical, Inc. | -357 Thousand USD | -115.126% |
Tactile Systems Technology, Inc. | 195.13 Million USD | 100.394% |
Inari Medical, Inc. | 434.56 Million USD | 100.177% |
UFP Technologies, Inc. | 112.22 Million USD | 100.684% |
QT Imaging Holdings, Inc. | - USD | Infinity% |
Heart Test Laboratories, Inc. | 12.51 Thousand USD | 6234.675% |
Tenon Medical, Inc. | 1.24 Million USD | 161.886% |
Autonomix Medical, Inc. Common Stock | -81 Thousand USD | -848.148% |
Co-Diagnostics, Inc. | 2.62 Million USD | 129.234% |
AdaptHealth Corp. | 479.56 Million USD | 100.16% |
Sintx Technologies, Inc. | 1.84 Million USD | 141.671% |
NanoVibronix, Inc. | 1.53 Million USD | 149.967% |
Quanterix Corporation | 70.64 Million USD | 101.087% |
Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | -89.163% |
Sensus Healthcare, Inc. | 14.06 Million USD | 105.462% |
Pacific Biosciences of California, Inc. | 52.78 Million USD | 101.455% |
TransMedics Group, Inc. | 154.09 Million USD | 100.498% |
ReWalk Robotics Ltd. | 4.45 Million USD | 117.247% |
NeuroMetrix, Inc. | 3.94 Million USD | 119.456% |
Hyperfine, Inc. | 4.75 Million USD | 116.145% |
Establishment Labs Holdings Inc. | 106.97 Million USD | 100.718% |
Biomerica, Inc. | 611 Thousand USD | 225.696% |
Bone Biologics Corporation | - USD | Infinity% |
AVITA Medical, Inc. | 41.68 Million USD | 101.842% |
Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 1.659% |
Silk Road Medical, Inc | 127.08 Million USD | 100.604% |